All Headlines >>
Neptra has been approved for the treatment of acute canine otitis externa or acute exacerbations of recurrent otitis caused by mixed infections of susceptible strains of bacteria sensitive to florfenicol (Staphylococcus pseudintermedius) and fungi sensitive to terbinafine (Malassezia pachydermatis), by the European Commission.
Mario Andreoli, Head of Marketing at Bayer Animal Health, said: "Otitis externa is a common disease in dogs and a leading cause why owners take their dog to a veterinarian.
"Neptra offers a key advantage, unlike competing products, it requires just one dose, administered by the veterinarian in the practice."
No at-home applications by the dog owner are required. The treatment stays in the hands of the vet who has full control over compliance.
Mario added: "With Neptra we provide a high-quality veterinary treatment that is convenient for the dog owner and ensures the well-being of dogs with a proper, effective application."
VetSurgeon understands the new product will be available in the UK in January 2020.
Whilst you're here, take a moment to see our latest job opportunities for vet nurses.
Veterinary Nurse Jobs and
Veterinary Nurse Locums |
Follow VN Jobs on Facebook | Linkedin | Twitter | Contact
Click here to learn more about display and email advertising on VetNurse.co.uk
Veterinary Forums | Veterinary Nursing News | Veterinary Galleries
Anaesthesia & Analagesia | Animal Behaviour | Dentistry | Dermatology | Veterinary Diagnostic Imaging | Equine Nursing | Exotics | Emergency & Critical Care | Lab/Clinical Pathology | Medical Nursing | Physiotherapy | Surgical Nursing | Wound Management